Revance Therapeutics

Ebitda Lave om Dato
AbbVie USD 6.75B 433M 2023-09
ALKERMES USD 68.51M 189.7M 2023-09
Bristol-Myers Squibb USD 4.89B 261M 2023-12
Eli Lilly USD 3.84B 1.88B 2023-09
Merck USD 7.51B 11.02B 2023-09
Neurocrine Biosciences USD 146.7M 68M 2023-09
Pacira USD 52.49M 12.98M 2023-12
Supernus Pharmaceuticals USD 40.87M 10.87M 2023-12



Revance Therapeutics - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.